KK
TYRA icon

KLP Kapitalforvaltning’s Tyra Biosciences TYRA Stock Holding History

KLP Kapitalforvaltning’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163K Buy
5,100
+2,200
+76% +$72.8K ﹤0.01% 1967
2026
Q1 		$111K Buy
+2,900
New +$93.9K ﹤0.01% 2027
2025
Q2 		– Sell
-2,200
Closed -$20.5K – 2262
2025
Q1 		$20.5K Hold
2,200
– – ﹤0.01% 2244
2024
Q4 		$30.6K Buy
+2,200
New +$39.9K ﹤0.01% 2276

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

KLP Kapitalforvaltning's TYRA Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Tyra Biosciences (TYRA) stake by 76% in Q2 2026, buying an estimated $72.8K and bringing the position to 5,100 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1967.

KLP Kapitalforvaltning first reported a position in TYRA in Q4 2024 and has held it in 4 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • KLP Kapitalforvaltning held 5,100 shares of Tyra Biosciences worth $163K as of Q2 2026.
  • KLP Kapitalforvaltning bought 2,200 Tyra Biosciences shares in Q2 2026, an estimated $72.8K.
  • Tyra Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1967 holding.
  • KLP Kapitalforvaltning first reported a position in Tyra Biosciences in Q4 2024 and has held it in 4 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.